Device type · NHL
Stimulator, Electrical, Implanted, For Parkinsonian Symptoms
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
NHL
Neurology
Device class
Class III
FDA decisions since 2015
4
510(k), De Novo and PMA
Adverse event reports
166
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Stimulator, Electrical, Implanted, For Parkinsonian Symptoms
- Product code
- NHL
- Device class
- Class III
- Review panel
- Neurology
- Specialty
- Neurology & Neurosurgery, Neuromodulation
- FDA record
- Classification database entry for NHL
Latest FDA decisions
P960009-S478 · Decided Feb 20, 2025 · 309 days after receipt · Panel Track
Device type: Stimulator, electrical, implanted, for parkinsonian symptoms (NHL) · Neurology & Neurosurgery
P150031-S064 · Decided Feb 29, 2024 · 153 days after receipt · Panel Track
Device type: Stimulator, electrical, implanted, for parkinsonian symptoms (NHL) · Neurology & Neurosurgery
- Vercise Deep Brain Stimulation (DBS) SystemPMA supplement
P150031-S028 · Decided Dec 29, 2020 · 365 days after receipt · Panel Track
Device type: Stimulator, electrical, implanted, for parkinsonian symptoms (NHL) · Neurology & Neurosurgery
1 more FDA decisions with a free account
Reports received
166
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
21
13% of reports
Injury reports
140
84% of reports
Death reports
5
3.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 3 | 21 | 1 | 0 |
| Jan 24 | 6 | 21 | 2 | 0 |
| Feb 24 | 9 | 24 | 1 | 0 |
| Mar 24 | 5 | 41 | 2 | 0 |
| Apr 24 | 4 | 39 | 0 | 0 |
| May 24 | 6 | 29 | 0 | 0 |
| Jun 24 | 6 | 34 | 2 | 0 |
| Jul 24 | 6 | 27 | 1 | 0 |
| Aug 24 | 7 | 34 | 2 | 0 |
| Sep 24 | 4 | 19 | 0 | 0 |
| Oct 24 | 5 | 48 | 0 | 0 |
| Nov 24 | 5 | 7 | 0 | 0 |
| Dec 24 | 2 | 2 | 0 | 0 |
| Jan 25 | 0 | 1 | 0 | 0 |
| Feb 25 | 0 | 3 | 0 | 0 |
| Mar 25 | 6 | 7 | 0 | 1 |
| Apr 25 | 4 | 13 | 1 | 0 |
| May 25 | 4 | 15 | 1 | 0 |
| Jun 25 | 3 | 19 | 0 | 0 |
| Jul 25 | 5 | 40 | 2 | 0 |
| Aug 25 | 0 | 10 | 0 | 0 |
| Sep 25 | 2 | 10 | 0 | 0 |
| Oct 25 | 3 | 13 | 0 | 0 |
| Nov 25 | 3 | 13 | 1 | 0 |
| Dec 25 | 0 | 14 | 0 | 0 |
| Jan 26 | 0 | 11 | 0 | 0 |
| Feb 26 | 1 | 15 | 0 | 0 |
| Mar 26 | 3 | 12 | 0 | 0 |
| Apr 26 | 2 | 10 | 0 | 0 |
| May 26 | 1 | 9 | 1 | 0 |
| Jun 26 | 5 | 11 | 1 | 0 |
| Jul 26 | 2 | 13 | 0 | 0 |
| Aug 26 | 2 | 10 | 1 | 0 |
| Sep 26 | 1 | 11 | 0 | 0 |
| Oct 26 | 1 | 11 | 1 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem62
- Unexpected Therapeutic Results44
- High impedance30
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions42
- Shaking/Tremors22
- Movement Disorder17
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Boston Scientific Neuromodulation Corporation
Z-2340-2025 · Started Jul 8, 2025 · Posted by FDA Aug 19, 2025
Reason given: Resistance and difficulties could occur while closing the retaining clip locking mechanism, which is part of a burr hole cover kit, which is part of a Deep Brain Stimulation (DBS) system, which may lead to procedural delay, or lead-migration-which may require additional surgery.
Cause as FDA categorized it: Component change control
- Vercise Deep Brain Stimulation Systems Surgical Implant Manual, Document Number: 92328632-09Open, Classified
Boston Scientific Neuromodulation Corporation
Z-2558-2025 · Started Jul 8, 2025 · Posted by FDA Sep 12, 2025
Reason given: Wire break(s) have occurred in rechargeable deep brain stimulation implantable pulse generators, implanted in the submuscular pectoral location. Wire breaks prevent successful stimulation, thus requiring device removal/replacement and users may experience high monopolar impedances, undesired sensation, loss of...
Cause as FDA categorized it: Labeling design
- Vercise Genus Deep Brain Stimulation (DBS) Implantable Pulse Generator IPG: R16 IPG KIT, REF: M365DB12160, and R32 IPG KIT, REF: M365DB12320Open, Classified
Boston Scientific Neuromodulation Corporation
Z-1890-2024 · Started Apr 18, 2024 · Posted by FDA May 24, 2024
Reason given: Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) may experience routine system check during IPG charging, which may cause device reset. The device reset could lead transient loss of stimulation; patients may experience undesired sensations, transient worsening of movement disorder symptoms, which may...
Cause as FDA categorized it: Device Design
1 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.